Abstract
Although strong associations, and genetic linkage between the Human Leukocyte Antigen (HLA) complex and susceptibility to a wide variety of autoimmune diseases has been documented for the last 30 years, the mechanisms by which genes in the major histocompatibility complex (MHC) mediate susceptibility to autoimmunity remain poorly understood.’ While the primary functions of the MHC Class I and Class II molecules—antigen presentation of peptides to the receptors on T-cells, and T-cell positive and negative selection in the thymus—are now well documented and at least partially delineated, the precise molecular mechanisms by which particular alleles of MHC Class I or Class II molecules increase or decrease susceptibility to autoimmune diseases have not yet been worked out.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. Tisch and H.O. McDevitt, Insulin-dependent diabetes mellitusCell85, 291–297 (1996).
Acha-Orbea and H.O. McDevitt, The first external domain of the non-obese diabetic mouse class II I-AB chain is uniqueProc. Natl. Acad. Sci.84(8), 4591–4595 (1987).
R. Tisch, X. Yang, S. M. Singer, R.S. Liblau, L. Fugger, and H.O. McDevitt, Immune response to glutamic acid decarboxylase correlates with insulitis onset in non-obese diabetic miceNature366(640), 72–75 (1993).
D.L. Kaufman, M. Clare-Saizler, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann, Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetesNature366(6450), 69–72 (1993).
D. Daniel and D. R. Wegmann, Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9–23)Proc. Natl. Acad. Sci.93, 956–960 (1996).
I. R. Cohen, Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetesAnmu. Rev. Immunol.9:567–589 (1991).
R. Tisch, R. S. Liblau, X-D. Yang, P. Liblau, and H. O. McDevitt, Induction of GAD 65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic miceDiabetes47(6), 1570–1577 (1998).
R. Tisch, B. Wang, and D. V. Serreze, Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent, J.Immunol.163(3), 1178–1187 (1999).
M. A. Atkinson, N. K. Maclaren, and R. Luchetta, Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapyDiabetes39(8), 933–937 (1990).
D. Elias, T. Reshef, O. S. Birk, R. van der Zee, M. D. Walker, and I. R. Cohen, Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65kDa heat shock proteinProc. Natl. Acad Sci.88(8), 3088–3091 (1991).
J-W. Yoon, C-S. Yoon, H-W. Lim, Q. Q. Huang, Y. Kang, K. H. Pyun, K. Hirasawa, R. S. Sherwin, H-S. Jun, Control of autoimmune diabetes in NOD Mice by GAD expression or suppression in B cellsScience284(5417), 1183–1187 (1999).
C-C. Chao, H-K. Sytwu, E. L. Chen, J. Toma, and H. O. McDevitt, The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoireProc. Natl. Acad. Sci.96(16), 9299–9304 (1999).
S. M. Singer, R. Tisch, X-D. Yang, H-K. Sytwu, R. S. Liblau, and H. O. McDevitt, Prevention of diabetes in NOD mice by a mutated I-Ab transgeneDiabetes47(10), 1570–1577 (1998).
G. Rammensee, T. Friede, and S. Stevanoviic, MHC ligands and peptide motifs: first listingImmunogenetics41(4), 178–228 (1995).
O. Kanagawa, S. M. Martin, B. A. Vaupel, E. Carrasco-Marin, and E. R. Unanue, Autoreactivity of T cells from nonobese diabetic mice: an I-A g7-dependent reactionProc. Natl. Acad. Sci.95(4), 1721–1724 (1998).
W. M. Ridgway, M. Fasso, A. Lanctot, C. Garvey, and C. G. Fathman, Breaking self-tolerance in nonobese diabetic mice, JExp. Med.183(4), 1657–1662 (1996).
N. R. Pritchard, A. J. Cutler, S. Uribe, S. J. Chadban, B. J. Morley, and K. G. C. Smith, Autoimmune-prone mice share a promoter haplotype associated with reduced expressino and function of the Fc receptor FcyRIICurr Bio110:227–230 (2000).
O. Rolandsson, E. Hagg, C. Hampe, E. P. Sullivan Jr., M. Nilsson, G. Jansson, G. Hallmans, and A. Lernmark, Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass indexDiabetologia42(5), 555–559 (1999).
M. Congia, S. Patel, A. P. Cope, S. De Virgiliis, and G. Sonderstrup, T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulinProc. Natl. Acad. Sci.95(7), 3833–3838 (1998).
A. E. Herman, R. Tisch, S. D. Patel, S. L. Parry, J. Olson, J. A. Noble, A. P. Cope, B. Cox, M. Congia, and H. O. McDevitt, Determination of autoantigenic peptides presented by the diabetes-associated HLA-DQ8 class II molecule identifies a motif and responses in individuals with typeIdiabetes,J. Immunol.163:6275–6282 (1999).
R. S. Abraham and C. S. David, Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic miceCurr. Opin. Immunol.12(1), 122–129 (2000).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
McDevitt, H. (2001). The Role of MHC Class II Molecules in the Pathogenesis and Prevention of Type I Diabetes. In: Gupta, S. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation VIII. Advances in Experimental Medicine and Biology, vol 490. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1243-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1243-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5458-1
Online ISBN: 978-1-4615-1243-1
eBook Packages: Springer Book Archive